4-boronophenylalanine has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartelink, H; Begg, AC; Gregoire, V; Huiskamp, R; Verrijk, R | 1 |
| Kinashi, Y; Kobayashi, T; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Takagaki, M | 1 |
2 other study(ies) available for 4-boronophenylalanine and EHS Tumor
| Article | Year |
|---|---|
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Topics: Animals; Boric Acids; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain; Dose-Response Relationship, Drug; Female; Half-Life; Injections, Intraperitoneal; Kidney; Liver; Male; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Phenylalanine; Radiation-Sensitizing Agents; Sarcoma, Experimental; Sulfhydryl Compounds; Time Factors | 1993 |
Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Topics: Animals; Apoptosis; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium; Carcinoma, Squamous Cell; Cytochalasin B; Fluorescent Antibody Technique; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Neoplasms; Neutrons; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Sarcoma, Experimental; Sulfhydryl Compounds; Tumor Cells, Cultured | 2001 |